BeOne Medicines Balance Sheet
NASDAQ: ONCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BeOne Medicines financial position
At the end of fiscal 2025, BeOne Medicines reported total assets of $8.19 billion, up 38.3% from a year earlier against total liabilities of $3.83 billion. Shareholders' equity stood at $4.36 billion, or 53.3% of assets. The company held $4.55 billion in cash and equivalents against $1.03 billion of debt, a net cash position of $3.52 billion.
The current ratio (current assets divided by current liabilities) was 3.41, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.24.
Summary generated from market data by MetaCap's automated system. Methodology
BeOne Medicines balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.55B | 2.63B | 3.17B | 3.87B | 4.38B | 1.38B | 618.01M | 712.94M | 239.60M | 87.51M |
| Short-Term Investments | — | — | 2.60M | 665.25M | 2.24B | 3.27B | 364.73M | 1.07B | 597.91M | 280.66M |
| Receivables | 865.08M | 676.28M | 358.03M | 173.17M | 483.11M | 60.40M | 70.88M | 41.06M | 29.43M | — |
| Inventory | 608.23M | 494.99M | 416.12M | 282.35M | 242.63M | 89.29M | 28.55M | 16.24M | 10.93M | — |
| Total Current Assets | 6.23B | 3.99B | 4.20B | 5.21B | 7.61B | 4.96B | 1.17B | 1.94B | 913.50M | 374.40M |
| Property, Plant & Equipment | 1.64B | 1.58B | 1.32B | 845.95M | 587.61M | 357.69M | 242.40M | 157.06M | 62.57M | 25.98M |
| Goodwill | — | — | — | 109.00K | 109.00K | 109.00K | 109.00K | 109.00K | 109.00K | — |
| Intangible Assets | 62.70M | 51.09M | 57.14M | 40.62M | 46.68M | 5.00M | 5.85M | 7.17M | 7.25M | — |
| Long-Term Investments | 61.68M | 128.93M | 89.64M | 91.78M | 100.79M | 49.34M | 0 | — | — | — |
| Total Assets | 8.19B | 5.92B | 5.81B | 6.38B | 8.54B | 5.60B | 1.61B | 2.25B | 1.05B | 405.81M |
| Accounts Payable | 479.04M | 405.00M | 315.11M | 294.78M | 262.40M | 231.96M | 122.49M | 113.28M | 69.78M | 11.96M |
| Short-Term Debt | 66.36M | 1.70B | 688.37M | 328.97M | 427.56M | 670.03M | 0 | 8.73M | 9.22M | — |
| Total Current Liabilities | 1.83B | 2.21B | 1.81B | 1.47B | 1.60B | 1.08B | 310.31M | 246.45M | 149.99M | 35.06M |
| Long-Term Debt | 961.91M | 166.48M | 197.62M | 209.15M | 202.11M | 183.64M | 83.31M | 40.78M | 9.22M | 17.28M |
| Total Liabilities | 3.83B | 2.59B | 2.27B | 2.00B | 2.40B | 1.73B | 633.93M | 496.04M | 362.25M | 52.91M |
| Shareholders' Equity | 4.36B | 3.33B | 3.54B | 4.38B | 6.13B | 3.87B | 962.21M | 1.74B | 669.81M | 352.91M |
| Retained Earnings | -8.32B | -8.61B | -7.96B | -7.08B | -5.08B | -3.55B | -1.96B | -1.01B | -330.52M | -237.41M |
| Total Debt | 1.03B | 1.87B | 885.98M | 538.12M | 629.68M | 853.67M | 83.31M | 49.51M | 18.44M | 17.28M |
| Net Cash (Debt) | 3.52B | 757.87M | 2.29B | 4.00B | 5.99B | 3.80B | 899.43M | 1.73B | 819.07M | 350.89M |
| Shares Outstanding | 1.44B | 1.39B | 1.36B | 1.36B | 1.33B | 1.19B | 801.34M | 776.26M | 592.07M | 515.83M |
This table shows 10 annual periods of BeOne Medicines's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ONC's reporting calendar. What is a balance sheet?